CRIS Current Research Information System

MIGLIOLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.286
AS - Asia 2.256
EU - Europa 1.608
SA - Sud America 250
AF - Africa 140
OC - Oceania 2
Totale 6.542
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.251
SG - Singapore 918
CN - Cina 537
HK - Hong Kong 301
SE - Svezia 289
GB - Regno Unito 273
VN - Vietnam 268
IT - Italia 223
DE - Germania 219
BR - Brasile 203
RU - Federazione Russa 107
IE - Irlanda 86
NL - Olanda 83
FR - Francia 79
IN - India 71
UA - Ucraina 67
BG - Bulgaria 56
KR - Corea 48
SC - Seychelles 43
CI - Costa d'Avorio 39
FI - Finlandia 34
CH - Svizzera 29
TG - Togo 26
JO - Giordania 24
JP - Giappone 24
AR - Argentina 22
ZA - Sudafrica 19
ID - Indonesia 18
CA - Canada 17
PL - Polonia 16
MX - Messico 12
IR - Iran 11
AT - Austria 9
EE - Estonia 9
ES - Italia 9
BD - Bangladesh 8
BE - Belgio 7
EC - Ecuador 7
CL - Cile 5
MY - Malesia 4
PY - Paraguay 4
RO - Romania 4
TR - Turchia 4
UZ - Uzbekistan 4
IQ - Iraq 3
KE - Kenya 3
LT - Lituania 3
NG - Nigeria 3
PE - Perù 3
PK - Pakistan 3
CO - Colombia 2
EG - Egitto 2
MA - Marocco 2
MD - Moldavia 2
NP - Nepal 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
VE - Venezuela 1
Totale 6.542
Salva come PNG Salva come JPEG
Città #
Singapore 567
Hong Kong 301
Chandler 287
Ashburn 247
Santa Clara 244
Southend 203
Boardman 119
Fairfield 104
Beijing 100
Princeton 97
Hefei 94
Ho Chi Minh City 91
Dublin 86
Hanoi 52
Sofia 52
Ann Arbor 51
Los Angeles 49
Wilmington 49
Houston 48
Seoul 46
Woodbridge 46
Berlin 42
Cambridge 42
Jacksonville 41
Abidjan 39
Seattle 37
New York 34
Helsinki 32
Frankfurt am Main 30
Bern 28
Lomé 26
Buffalo 25
Amman 24
Bologna 24
Dong Ket 24
Falkenstein 24
Milan 24
Nanjing 21
Guangzhou 19
Tokyo 19
Turin 18
Padova 16
Westminster 16
Dallas 14
Redondo Beach 14
Chicago 13
Rome 13
Bengaluru 12
Shanghai 12
São Paulo 12
Warsaw 12
Haiphong 11
Boston 10
San Diego 10
Wuhan 10
Da Nang 9
Düsseldorf 9
London 9
Orem 9
Poplar 9
Yubileyny 9
Columbus 8
Curitiba 8
Jinan 8
Mumbai 8
Munich 8
Olalla 8
Amsterdam 7
Brussels 7
Hải Dương 7
Kyiv 7
Montreal 7
Mountain View 7
Mülheim 7
Nanchang 7
Nuremberg 7
Shenyang 7
Belo Horizonte 6
Biên Hòa 6
Hangzhou 6
Phoenix 6
Salt Lake City 6
Shijiazhuang 6
Vũng Tàu 6
Zhengzhou 6
Brooklyn 5
Changsha 5
Chennai 5
Denver 5
Jakarta 5
Manaus 5
Medford 5
Mexico City 5
Saint Petersburg 5
Salvador 5
Shenzhen 5
Springfield 5
Stockholm 5
Tianjin 5
Washington 5
Totale 3.976
Salva come PNG Salva come JPEG
Nome #
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 228
Erosions or not in GORD? The potential role of oesophageal cell proliferation 219
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 197
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 197
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 197
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 184
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 180
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 179
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 174
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 174
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 165
Diagnosi dell’infezione da Helicobacter pylori 157
Erosions or not in GERD? The potential role of esophageal cell kinetics 153
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 153
Diagnosi non invasiva e terapia per Helicobacter Pylori 145
Peptic ulcer and Helicobacter pylori. 136
Three-year experience in clinical intestinal transplantation 136
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 116
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 92
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 89
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 86
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 86
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 79
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 79
Interleukin 1 in ulcerative colitis 78
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 77
Role of rectal formulations: Enemas 76
Macrophage subpopulations in pouchitis 75
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 74
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 73
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 72
Bronchopulmonary involvement in ulcerative colitis 72
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 72
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 71
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 71
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 70
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 69
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 69
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 66
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 66
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 64
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 64
Pentasa in maintenance treatment of ulcerative colitis 63
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 63
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 61
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 54
Rifaximin suspension for the eradication of helicobacter pylori 53
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 52
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 50
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 48
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 46
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 44
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 44
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 43
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 42
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 39
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 39
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 37
High eradication rates of Helicobacter pylori with a new sequential treatment 34
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 34
High eradication rates of Helicobacter pylori with a new sequential treatment 33
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 29
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 29
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 29
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 29
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 27
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 27
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 27
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 26
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 26
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 26
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 25
Susceptibility of Helicobacter pylori to Metronidazole 25
Lactose Malabsorption in Adult Patients with Crohn's Disease 25
Review article: Diagnosis of Helicobacter pylori infection 24
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 24
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 22
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 22
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 22
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 22
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 22
Optimal nutritional indexes in gastroenterology 20
Source of Helicobacter pylori Infection 19
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 19
Routes of trasmission of Helicobacter pylori infection 19
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 18
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 18
Biliary surgery without the surgeon! 17
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 17
Therapeutic news on Helicobacter pylori from Budapest and Wien 16
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 16
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 16
Helicobacter pylori: Diseases, tests and treatment 15
Symptoms and Helicobacter pylori: Any link [6] 15
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 15
null 15
Therapeutic news on Helicobacter pylori from Budapest and Wien 14
Helicobacter pylori seroconversion in asymptomatic blood donors: A five-year follow-up 14
Treatment of symptom-free Helicobacter pylori-positive subjects 14
Low levels of essential fatty acids in the red blood cell membrane phospholipid fraction of long-term home parenteral nutrition patients [1] 14
Totale 6.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 17 2 12 14 15 14 47
2021/2022687 19 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/20251.807 59 189 133 101 405 88 130 70 27 136 56 413
2025/20261.860 299 309 348 289 407 208 0 0 0 0 0 0
Totale 6.688